Triochem Product

Triochem_Product24 Sep 2015

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Triochem Product

Triochem Product

Pharmaceuticals

Triochem_Product24 Sep 2015

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
15-Mar-2024	BC	TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2024 inter alia to consider and approve Pursuant to the Regulation 25(3) of the	28-Mar-2024
31-Jan-2024	BC	TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to the provision of SEBI [Listi	09-Feb-2024
26-Oct-2023	BC	TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve Pursuant to the provision of SEBI [Listi	04-Nov-2023
26-May-2023	BC	AGM 24/08/2023 We would like to inform you that, pursuant to Notice of Board meeting dated 16th May 2023 the Board Meeting of the Company was held today Friday 26th May 2023 at 2.00 p.m. at 4th Fl	24-Aug-2023
26-May-2023	BC	Annual General Meeting	18-Aug-2023

No Rights has been declared by Triochem_Product

Book Closure

Record Date	Split Date	Purpose
28-Mar-2024	-	TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2024 inter alia to consider and approve Pursuant to the Regulation 25(3) of the
09-Feb-2024	-	TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to the provision of SEBI [Listi
04-Nov-2023	-	TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve Pursuant to the provision of SEBI [Listi
24-Aug-2023	-	AGM 24/08/2023 We would like to inform you that, pursuant to Notice of Board meeting dated 16th May 2023 the Board Meeting of the Company was held today Friday 26th May 2023 at 2.00 p.m. at 4th Fl
18-Aug-2023	01 Jan'1900	Annual General Meeting

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Triochem Products Ltd ₹17.40(0.00/0.00%)	17.40	+0.00	0.43	0.00	0.00	0.04
Astrazeneca Pharma India Ltd ₹5,390.10(+56.25/1.05%)	5,390.10	+56.25	13,334.63	67.79	83.60	20.36
Bliss GVS Pharma Ltd ₹119.65(-9.55/-7.39%)	119.65	-9.55	1,352.61	67.42	19.82	1.38
Cipla Ltd ₹1,420.85(+1.30/0.09%)	1,420.85	+1.30	114,613.75	54.95	34.85	4.43
Amrutanjan Health Care Ltd ₹772.35(-14.25/-1.81%)	772.35	-14.25	2,274.11	29.81	51.68	8.68
Abbott India Ltd ₹26,121.05(-483.30/-1.82%)	26,121.05	-483.30	56,534.24	18.89	49.35	18.18

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.04	0.05	0.14	0.07	0.03	0.07
Total Income	0.04	0.05	0.14	0.07	0.03	0.07
Total Expenditure	0.23	1.45	0.26	0.31	0.33	0.36
PBIDT	-0.20	-1.40	-0.12	-0.24	-0.30	-0.29
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.20	-1.40	-0.12	-0.24	-0.30	-0.29
Depreciation	0.02	0.02	0.02	0.03	0.03	0.03
Tax	0.00	0.00	0.00	0.00	0.00	-0.01
Deferred Tax	-0.01	-0.39	-0.03	-0.07	-0.08	-0.07
Reported Profit After Tax	-0.20	-1.03	-0.11	-0.20	-0.25	-0.25
Extra-ordinary Items	0.00	-1.16	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.20	0.13	-0.11	-0.20	-0.25	-0.25

EPS (Unit Curr.)	-8.34	-41.85	-4.40	-8.11	-10.11	-10.03
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Unit Curr.)	-8.34	-41.85	-4.40	-8.11	-10.11	-10.03
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Ann.) (Unit Curr.)	-33.37	-167.41	-17.62	-32.46	-40.44	-40.11
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	0.25	0.25	0.25	0.25	0.25	0.25
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	0.25	0.25	0.25	0.25	0.25	0.25
Reserves Total	11.35	12.80	11.47	11.93	8.53	7.79
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	11.60	13.05	11.72	12.18	8.78	8.04
Secured Loans	0.00	0.00	0.00	1.25	3.49	1.53
Unsecured Loans	0.00	0.00	0.00	1.25	2.30	0.75
Total Debt	0.00	0.00	0.00	2.50	5.79	2.28
Total Liabilities	11.60	13.05	11.72	14.68	14.57	10.32
APPLICATION OF FUNDS :
Gross Block	2.02	2.02	1.97	1.95	1.95	1.94
Less : Accumulated Depreciation	1.26	1.15	1.03	0.89	0.73	0.52
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.76	0.87	0.94	1.06	1.22	1.42
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.03	0.03	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	9.42	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.05	0.05	0.85	1.55	9.57	8.23
Sundry Debtors	0.00	0.00	1.39	12.40	3.33	0.00
Cash and Bank	0.96	11.81	8.20	0.55	0.25	0.92
Loans and Advances	0.27	0.18	0.56	0.86	0.69	0.80
Total Current Assets	1.28	12.04	11.00	15.37	13.84	9.95
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.19	0.18	0.33	1.68	0.37	0.73
Provisions	0.05	0.03	0.06	0.17	0.09	0.63
Total Current Liabilities	0.24	0.21	0.39	1.85	0.46	1.35
Net Current Assets	1.04	11.83	10.61	13.52	13.38	8.59
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.36	0.00	0.04	0.00	0.00	0.02
Deferred Tax Liability	0.08	0.07	0.00	0.09	0.12	0.15
Net Deferred Tax	0.28	-0.07	0.04	-0.09	-0.12	-0.13
Total Assets	11.51	12.63	11.62	14.52	14.48	9.88
Contingent Liabilities	0.03	0.03	0.03	0.03	0.03	0.03

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	11.81	8.20	0.55	0.25	0.92
Net Cash from Operating Activities	-1.58	3.47	10.25	3.82	-3.75
Net Cash Used In Investing Activities	-9.27	0.16	0.00	-0.03	0.02
Net Cash Used In Financing Activities	0.00	-0.02	-2.61	-3.49	3.06
Net Inc./Dec In Cash And Cash Equivalents	-10.85	3.61	7.64	0.30	-0.67
Cash And Cash Equivalents At End Of The Year	0.96	11.81	8.20	0.55	0.25

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

68.65%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

31.35%

**Promoter pledged shareholding 68.65%

About Triochem Products Ltd

Triochem Products Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 0.43 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.2 crores for the quarter ended December 2018. The company management includes , Ramu S Deora,Sunil S Jhunjhunwala,S S Sharma,Girish Kumar Pungalia,Rajesh Ramu Deora,Ureca Shirish Shirole,Grace R. Deora (Triochem Products Ltd) among others.

Chairman

Registered office

Sambhava Chambers,4th Floor Sir P M Road,Mumbai,Maharashtra,400001

FAX :91-22-22024657

Background

Incorporation Year1972

Face Value₹10

Market Lot1

How to buy Triochem Product shares on nse?

To buy Triochem Product shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Triochem Product share price today?

The Triochem Product shares price on nse is Rs.17.4 today.

What is the market cap of Triochem Product shares on BSE ?

The company has a market capitalization of Rs.0.43Cr

What is the PE & PB ratio of Triochem Product shares ?

PE is 0 and PB is 0.04

What is the 52 Week High and Low of Triochem Product shares?

Triochem Product stock price high: Rs.17.4 Triochem Product stock price low: Rs.0